Coala Life is a Swedish medical developer on a mission to digitally transform the field of cardiac diagnostics, to help win the battle against the world’s leading cause of death - the heart. It’s about predicting and preventing cardiac disease, powered by smart algorithms and the individual.
Our contribution is to provide mankind with digital, medical solutions to be able to follow their hearts themselves, driven by smart algorithms while at the same time collect data to benefit cardiac research.
Our unique innovations are based on more than a decade of Swedish research and development and honored by multiple awards. The solutions are used by thousands of individuals and hundreds of healthcare providers are connected to the Coala Care platform.
We make it possible for everyone to monitor and analyze their heart. Anytime, anywhere.
Coala Life is run by an entrepreneurial team with broad knowledge, passion and experience in the heart. Many with long careers at St. Jude Medical (now Abbott). In collaboration with clinicians and industry experts, and more than USD 20 million in funding, we've developed and launched a multi-prize-winning portfolio of cardiac monitoring solutions.
It's all centered around the Coala Heart Monitor, a cloud-based product and service for real-time analysis of the heart.The Coala Heart Monitor is unique in detecting Atrial Fibrillation based on both P-wave detection and RR variability, as well as the ability to help detect murmurs instantly.
Liselott Kilaas (chair), Johanna Öberg, Ebba Fåhraeus, Sören Olofsson, Anders Rodebjer and Jan Flood.
Liselott has an impressive career as, among others, CEO of Aleris, the largest private healthcare provider in the Nordics. Liselott has been on the Board of Telenor ASA and the Central Bank of Norway, to mention a few assignments. Sören has been the CEO of some of Swedens largest hospitals, he laid the foundation of e-health in Sweden and he advises the European Union on digitization of health. Johanna is the CEO of Memira, the largest healthcare provder in the Nordics within eye lens replacement surgery. Ebba is a super star of entrepreneurship and innovation, and among others, the CEO of SmiLe Incubator. Anders R has medical degree and is the super corporate finance guy. Jan is a great lawyer and one of the founding investors of the company.
Tord Juhlin, MD, PhD, Senior consultant and Cardiologist, Skåne University Hospital, Sweden. Tord is also the Chairman of the Swedish Cardiology Societies Heart Rhythm Group (HRG).
Hans-Jörgen Nilsson, MD, PhD, Workstream Lead Cardiology, Senior consultant and Cardiologist, Skåne University Hospital, Sweden. Hans-Jörgen is currently active in the cardiology implementation of new region wide EMR system in Region Skåne.
Claes Held, MD, PhD, Senior consultant and Professor in Cardiology, Akademiska Hospital Uppsala (The Uppsala University Hospital), Sweden. Claes is also a researcher active at Uppsala Clinical Research Center (UCR)
Ulf Tossman, PhD Neuropharmacology, CEO Orphelion AB, Co-founder of Coala Life AB. Ulf is also chairman/board member of several Swedish Life-science companies.
The Coala investors include prominent doctors, professors, entrepreneurs, life science experts, business angels, institutional investors, family offices, the management team and lots of ordinary people sharing our mission and vision. USD 20 million invested so far. Thank you.
Coala Life has been honored by over 15 industry awards and recognitions for its innovations including The Grand Award of Swedish Design, elected as one of five Cool Vendors by Gartner, elected as the leading MedTech company in Sweden, listed on the Global 100 Digital Health Companies by the Journal of mHealth, honored with the Rising Star Award by the Swedish American Life Science Summit etc.
STOCKHOLM April 24, 2019 – Coala Life today announces the closing of an A-series round of approximately USD 10 million (SEK 92 million) raised from Swedish institutional and private investors. The proceeds are intended to accelerate the commercialization and establish the company on the US market. Investors include 20 North Street, Larry Leksell, Anders Nyrén …
Gothenburg, April 11, 2019 – New research presented today at the 21st Swedish Cardiovascular Spring Meeting in Gothenburg confirms the detection accuracy of the Coala Heart Monitor and it s sequential combination of digital chest- and thumb-ECG. The 2-lead ECG method and instant cloud-based mobile platform proves significantly increased accuracy of detetcing Atrial Fibrillation as …
Stockholm, Sweden, February 14th, 2019 – Coala Life AB announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Coala Heart Monitor. The Coala is a novel mobile and cloud based solution with an integrated electrocardiogram (ECG) and digital stethoscope, ideal for remote monitoring of heart conditions. Coala’s …